Project Description

In The Media…

Conquer Magazine

January 14, 2022

In this CONQUER article, Dr. Matthew Allaway, founder and president of Perineologic, discusses how his personal experience with cancer led to the development of PrecisionPoint™ – an important care option that supports the detection of prostate cancer while reducing the risk of infection

“Developing the PrecisionPoint™ system has been extremely rewarding to me, and together with other urologists, we are working to make it the standard of care in the United States and around the world, to ensure that all men can have the benefits of a better, safer, and more precise biopsy.”

Dr. Matthew Allaway, President & Founder, Perineologic

Share This Page...

Share This Page...


Have a Question? Contact Us!

Thank you for your interest in Perineologic®!

    Other Ways to Contact Us